acetylcarnitine has been researched along with Fra(X) Syndrome in 9 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The fragile X syndrome is caused by a >200 CGG repeat expansion within the FMR1 gene promoter, with consequent DNA hypermethylation and inactivation of its expression." | 1.33 | Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. ( Chiurazzi, P; Moscato, U; Neri, G; Oostra, BA; Pietrobono, R; Tabolacci, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rueda, JR | 2 |
| Guillén, V | 1 |
| Ballesteros, J | 2 |
| Tejada, MI | 2 |
| Solà, I | 1 |
| Hall, SS | 1 |
| Calvani, M | 4 |
| D'Iddio, S | 2 |
| de Gaetano, A | 2 |
| Mariotti, P | 2 |
| Mosconi, L | 1 |
| Pomponi, MG | 3 |
| Tabolacci, E | 3 |
| Torrioli, MG | 3 |
| Vernacotola, S | 3 |
| Neri, G | 6 |
| Pascale, E | 1 |
| Battiloro, E | 1 |
| Cimino Reale, G | 1 |
| Pietrobono, R | 2 |
| Chiurazzi, P | 4 |
| Nicolai, R | 1 |
| D'Ambrosio, E | 1 |
| Moscato, U | 2 |
| Oostra, BA | 1 |
| Peruzzi, L | 1 |
| Mila, M | 1 |
| Militerni, R | 1 |
| Musumeci, S | 1 |
| Ramos, FJ | 1 |
| Frontera, M | 1 |
| Sorge, G | 1 |
| Marzullo, E | 1 |
| Romeo, G | 1 |
| Vallee, L | 1 |
| Veneselli, E | 1 |
| Cocchi, E | 1 |
| Garbarino, E | 1 |
| Bianchi, E | 1 |
3 reviews available for acetylcarnitine and Fra(X) Syndrome
| Article | Year |
|---|---|
L-acetylcarnitine for treating fragile X syndrome.
Topics: Acetylcarnitine; Administration, Oral; Adolescent; Attention Deficit Disorder with Hyperactivity; Ch | 2015 |
Systematic review of pharmacological treatments in fragile X syndrome.
Topics: Acetylcarnitine; Dioxoles; Folic Acid; Fragile X Syndrome; Humans; Methylphenidate; Piperidines; Tre | 2009 |
Treatments for fragile X syndrome: a closer look at the data.
Topics: Acetylcarnitine; Adrenergic alpha-Agonists; Behavior Therapy; Central Nervous System Stimulants; Clo | 2009 |
3 trials available for acetylcarnitine and Fra(X) Syndrome
| Article | Year |
|---|---|
[L-acetylcarnitine treatment on fragile X patients hyperactive behaviour].
Topics: Acetylcarnitine; Child; Child Behavior Disorders; Clinical Trials as Topic; Fragile X Syndrome; Huma | 2001 |
A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
Topics: Acetylcarnitine; Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Meth | 2008 |
Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome.
Topics: Acetylcarnitine; Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Meth | 1999 |
3 other studies available for acetylcarnitine and Fra(X) Syndrome
| Article | Year |
|---|---|
Modulation of methylation in the FMR1 promoter region after long term treatment with L-carnitine and acetyl-L-carnitine.
Topics: Acetylcarnitine; Carnitine; Cells, Cultured; DNA Methylation; Fragile X Mental Retardation Protein; | 2003 |
Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments.
Topics: Acetylation; Acetylcarnitine; Azacitidine; Cell Line; Chromatin Immunoprecipitation; Decitabine; DNA | 2005 |
Butyrate and acetyl-carnitine inhibit the cytogenetic expression of the fragile X in vitro.
Topics: Acetylation; Acetylcarnitine; Adolescent; Adult; Aged; Butyrates; Butyric Acid; Cells, Cultured; Chi | 1994 |